Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[The loss of heterozygosity on the short arm of chromosome 3 in renal carcinoma].
Maestro de las Casas ML, del Barco Barriuso V, Moreno Sierra J, Izquierdo López L, Sanz Casla MT, Zanna I, Redondo González E, Chicharro Almarza J, Fernández Pérez C, Resel Estévez L. Maestro de las Casas ML, et al. Among authors: zanna i. Arch Esp Urol. 1999 Jan-Feb;52(1):3-9. Arch Esp Urol. 1999. PMID: 10101881 Spanish.
Loss of heterozygosity on the short arm of chromosome 3 in renal cancer.
Maestro ML, del Barco V, Sanz-Casla MT, Moreno J, Adrover E, Izquierdo L, Zanna I, Fernández C, Redondo E, Blanco J, Resel L. Maestro ML, et al. Among authors: zanna i. Oncology. 2000 Aug;59(2):126-30. doi: 10.1159/000012149. Oncology. 2000. PMID: 10971171
Loss of heterozygosity and methylation of p16 in renal cell carcinoma.
Sanz-Casla MT, Maestro ML, del Barco V, Zanna I, Moreno J, Vidaurreta M, Almansa I, Fernández C, Blanco J, Maestro C, Resel L. Sanz-Casla MT, et al. Among authors: zanna i. Urol Res. 2003 Jul;31(3):159-62. doi: 10.1007/s00240-003-0308-3. Epub 2003 Mar 25. Urol Res. 2003. PMID: 12883879
Prognostic significance of p16INK4a alterations and 9p21 loss of heterozygosity in locally advanced laryngeal squamous cell carcinoma.
Bazan V, Zanna I, Migliavacca M, Sanz-Casla MT, Maestro ML, Corsale S, Macaluso M, Dardanoni G, Restivo S, Quintela PL, Bernaldez R, Salerno S, Morello V, Tomasino RM, Gebbia N, Russo A. Bazan V, et al. Among authors: zanna i. J Cell Physiol. 2002 Sep;192(3):286-93. doi: 10.1002/jcp.10138. J Cell Physiol. 2002. PMID: 12124774
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.
Silvestri V, Barrowdale D, Mulligan AM, Neuhausen SL, Fox S, Karlan BY, Mitchell G, James P, Thull DL, Zorn KK, Carter NJ, Nathanson KL, Domchek SM, Rebbeck TR, Ramus SJ, Nussbaum RL, Olopade OI, Rantala J, Yoon SY, Caligo MA, Spugnesi L, Bojesen A, Pedersen IS, Thomassen M, Jensen UB, Toland AE, Senter L, Andrulis IL, Glendon G, Hulick PJ, Imyanitov EN, Greene MH, Mai PL, Singer CF, Rappaport-Fuerhauser C, Kramer G, Vijai J, Offit K, Robson M, Lincoln A, Jacobs L, Machackova E, Foretova L, Navratilova M, Vasickova P, Couch FJ, Hallberg E, Ruddy KJ, Sharma P, Kim SW; kConFab Investigators; Teixeira MR, Pinto P, Montagna M, Matricardi L, Arason A, Johannsson OT, Barkardottir RB, Jakubowska A, Lubinski J, Izquierdo A, Pujana MA, Balmaña J, Diez O, Ivady G, Papp J, Olah E, Kwong A; Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON); Nevanlinna H, Aittomäki K, Perez Segura P, Caldes T, Van Maerken T, Poppe B, Claes KB, Isaacs C, Elan C, Lasset C, Stoppa-Lyonnet D, Barjhoux L, Belotti M, Meindl A, Gehrig A, Sutter C, Engel C, Niederacher D, Steinemann D, Hahnen E, Kast K, Arnold N, Varon-Mateeva R, Wand D, Godwin AK, Evans DG, Frost D, Perkins J, Adlard J, Izatt L,… See abstract for full author list ➔ Silvestri V, et al. Among authors: zanna i. Breast Cancer Res. 2016 Feb 9;18(1):15. doi: 10.1186/s13058-016-0671-y. Breast Cancer Res. 2016. PMID: 26857456 Free PMC article.
p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-up.
Russo A, Migliavacca M, Zanna I, Valerio MR, Latteri MA, Grassi N, Pantuso G, Salerno S, Dardanoni G, Albanese I, La Farina M, Tomasino RM, Gebbia N, Bazan V. Russo A, et al. Among authors: zanna i. Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1322-31. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12433709
DNA aneuploidy and high proliferative activity but not K-ras-2 mutations as independent predictors of clinical outcome in operable gastric carcinoma: results of a 5-year Gruppo Oncologico dell'Italia Meridonale (GDIM) prospective study.
Russo A, Bazan V, Migliavacca M, Tubiolo C, Macaluso M, Zanna I, Corsale S, Latteri F, Valerio MR, Pantuso G, Morello V, Dardanoni G, Latteri MA, Colucci G, Tomasino RM, Gebbia N. Russo A, et al. Among authors: zanna i. Cancer. 2001 Jul 15;92(2):294-302. doi: 10.1002/1097-0142(20010715)92:2<294::aid-cncr1322>3.0.co;2-9. Cancer. 2001. PMID: 11466682
70 results